Introduction: Given the impact of COVID-19 on the world healthcare system, and the efforts
of the healthcare community to find prognostic factors for hospitalization, disease …

Background & Aims The evolution and clinical significance of abnormal liver chemistries and
the impact of hepatitis B infection on outcome in patients with COVID-19 is not well …

Background The most dreaded pandemic grappling world now, the Coronavirus Disease
2019 (COVID-19), chiefly involves the respiratory system; nevertheless, it is a multisystem …

Prognostic markers are needed to understand the disease course and severity in patients
with Covid-19. There is evidence that Covid-19 causes gastrointestinal symptoms and …

Objectives We aimed to investigate how changes in direct bilirubin (DBiL) levels in
severely/critically ill the coronavirus disease (COVID-19) patients during their first week of …

Objectives: The coronavirus disease (COVID-19) pandemic has caused a large number of
deaths. Some patients with severe or critical COVID-19 have been observed to have …

Aim An urgent need to define clinical and laboratory parameters to predict progression to the
severe and lethal forms of Coronavirus Disease 2019 (COVID‐19). To investigate the …

Background: One of the most critical health issues in the world is the COVID-19 pandemic
from the Coronaviridae family. There is a lack of knowledge regarding the disease, and liver …

Background Coronavirus disease 2019 (COVID-19) has caused a global pandemic
unprecedented in over a century, with≈ 35 million cases, and more than 1 million deaths …

Aim Elevation of hepatic aminotransferases (aspartate aminotransferase [AST]/alanine
aminotransferase [ALT]) is commonly noted among COVID-19 patients. It is unclear if they …